SynopsisClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Clofarabine market size is expected to reach US$ 663 million by 2029.....
SynopsisClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Clofarabine Drugs market size is expected to reach US$ 663 million b.....
SynopsisClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Clolar market size is expected to reach US$ 663 million by 2029, gro.....
SynopsisClofarabine is a purine nucleoside antimetabolite in Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Evoltra market size is expected to reach US$ 428.6 million by 2029, growing at a CAGR of 8.1% from 2023 to 20.....
Synopsisbuffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. The global Buffered Intr.....
Synopsisbuffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. The global Buffered Intr.....
SynopsisElliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. The global Elliotts B Solution market size is expected t.....
SynopsisErwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also .....
SynopsisErwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also .....
SynopsisErwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also .....








